AKT1 and breast cancer: This was also seen in cancer-associated fibroblasts (CAFs) isolated from human breast cancers where tumor suppressor p16INK4A downregulation led to increased Akt/mTOR signaling also affecting HIF-α positively and further increasing the VEGF-A secretion.